181 Neb. Admin. Code, ch. 8, § 003

Current through September 17, 2024

Section 181-8-003 - [Effective until 3/29/2024] PUBERTY BLOCKING DRUGS

Prior to prescribing, dispensing, or administering puberty blocking drugs for the treatment of gender nonconformity or gender dysphoria to a patient who has not reached the age of majority, the prescribing practitioner must meet the following:

(A) Obtain three hours of Category 1 Continuing Competency Education for prescribing drugs for the purpose of treating gender nonconformity or gender dysphoria within the most recent biennial renewal period;

(B) Determine or document:

(i) That gender nonconformity or gender dysphoria is driving the patient's distress and not other mental or physical health conditions, that there is no reasonable expectation of natural resolution of gender nonconformity, and that there has been a long-lasting and intense pattern of gender nonconformity or gender dysphoria which began or worsened at the start of puberty;

(ii) The severity of other mental or physical health conditions is being properly addressed and treated, and will not negatively impact treatment;

(iii) Puberty blocking treatment is not likely to negatively impact, or exacerbate other mental or physical health conditions;

(iv) The patient has received at least 40 contact hours of therapeutic treatment as required by this chapter;

(v) The patient has at least six consecutive months of living primarily as the preferred gender;

(vi) For individuals not suffering from gender dysphoria or for whom a clinical diagnosis of gender dysphoria is not available, that without puberty blocking treatment the patient will experience harm;

(vii) Tanner stage of puberty development and if puberty blockers would be effective; and

(viii) The appropriate supports are in place for the patient including appropriate social, and familial supports prior to initiating puberty blocking treatment;

(C) Discuss the following with the patient and parent or legal guardian or the patient, if the patient is an emancipated minor:

(i) The recommended dosage and route of treatment for the puberty blockers; and

(ii) The minimum waiting period of seven calendar days as required by this chapter;

(D) Obtain signed informed consent and patient assent as required by this chapter; and

(E) Document all the foregoing in the patient's medical record.

181 Neb. Admin. Code, ch. 8, § 003

Adopted effective 10/1/2023

Amended effective 1/2/2024, exp. 3/29/2024 (Emergency)